0000899243-22-026893.txt : 20220727
0000899243-22-026893.hdr.sgml : 20220727
20220727183627
ACCESSION NUMBER: 0000899243-22-026893
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220727
FILED AS OF DATE: 20220727
DATE AS OF CHANGE: 20220727
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gryaznov Sergei
CENTRAL INDEX KEY: 0001913228
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41455
FILM NUMBER: 221112260
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAIA Biotechnology, Inc.
CENTRAL INDEX KEY: 0001878313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
BUSINESS PHONE: 312-416-8592
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2022-07-27
0
0001878313
MAIA Biotechnology, Inc.
MAIA
0001913228
Gryaznov Sergei
444 WEST LAKE STREET, SUITE 1700
CHICAGO
IL
60606
0
1
0
0
Chief Scientific Officer
Common Stock
21511
D
Stock Options
1.80
2029-11-30
Common Stock
200000
D
Stock Options
1.80
2029-11-30
Common Stock
58000
D
Stock Options
1.80
2030-04-01
Common Stock
54000
D
Stock Options
1.80
2030-11-02
Common Stock
236493
D
Stock Options
1.80
2030-12-31
Common Stock
23695
D
Stock Options
1.83
2031-04-15
Common Stock
164662
D
Stock Options
1.83
2031-04-15
Common Stock
78413
D
Stock Options
1.83
2031-03-31
Common Stock
23078
D
Stock Options
1.83
2031-04-15
Common Stock
50000
D
Stock Options
1.83
2031-06-30
Common Stock
7529
D
Mr. Gryaznov beneficially owns 21,511 shares of common stock.
Represents an option to purchase shares of Common Stock granted pursuant to the 2018 Stock Option Plan. These options fully vested on .December 1, 2019.
Represents an option to purchase shares of Common Stock granted pursuant to the 2018 Stock Option Plan. These options vested in four equal monthly installments on December 1, 2019.
Represents an option to purchase shares of Common Stock granted pursuant to the 2018 Stock Option Plan. 6,055 of these options vested on April 30, 2020 and 47,945 of these options vested on January 1, 2021.
Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on November 3, 2020.
Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options vested in 90 equal daily instalments beginning on January 1, 2021.
Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on May 20, 2021.
Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on May 20, 2021.
Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options vested in 90 equal daily instalments beginning on April 2, 2021.
Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options vested in 36 equal monthly instalments beginning on January 1, 2021.
Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on July 1, 2021.
/s/ Sergei M. Gryaznov
2022-07-27